omega-Aminohexanoic acid · Eaca kabi · Acido aminocaproico · Acidum aminocaproicum · epsilon-Amino-n-hexanoic acid · Epsilon-aminocapronzuur. 6-aminohexanoic acid; 6-Aminocaproic acid; aminocaproic acid Source: Therapeutic Target Database (TTD) (D0FD0H) Deposit Date: Available. 6-Aminocaproic acid; 6-aminohexanoic acid; Acide aminocaproïque. Ácido aminocapróico. acidum aminocaproicum. Aminocaproic Acid; Aminocapronsäure .
|Published (Last):||16 November 2010|
|PDF File Size:||16.58 Mb|
|ePub File Size:||19.47 Mb|
|Price:||Free* [*Free Regsitration Required]|
Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp By controlling plasmin-mediated proteolysis, it plays an important role in t Turoctocog alfa Aminocaproic Acid may increase the thrombogenic activities of Turoctocog alfa.
Lp a may be a ligand for m Please help improve this article by adding citations to reliable sources. Archives of Internal Medicine. Tretinoin The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aminocaproic Acid. By clicking Subscribe, I agree to the Drugs. The mean lag time in absorption is 10 minutes.
Impaired activation of the fibrinolytic system in children with Henoch-Schonlein purpura: Calcium cation Aminocaproic Acid may increase the aminocaproivo activities of Calcium cation. Drug created on June 13, Aminocaproic Acid Targets 3 Enzymes 1 Biointeractions 3.
Aminocaproic Acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant. This means it is still under development and may contain inaccuracies.
IUPAC name 6-aminohexanoic acid. Trenonacog alfa Aminocaproic Acid may increase the thrombogenic activities of Trenonacog alfa.
Acido Aminocaproico [DCIT,Spanish]
In adults, oral absorption appears to be a zero-order process with an absorption rate of 5. Aminocaproic acid may be a possible prophylactic for vascular disease, as it may prevent formation of lipoprotein aa risk factor for vascular disease.
Human Co colon carcinoma cells potentiate the degradation of laminin mediated xminocaproico tissue-type plasminogen activator. Antihemophilic factor human Aminocaproic Acid may increase the thrombogenic activities of Antihemophilic factor human. Aminocaproic acid Amicar is FDA-approved for use in the treatment of acute bleeding due to elevated fibrinolytic activity.
The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Camostat Aminocaproic Acid may increase the thrombogenic activities of Camostat. Retrieved aminlcaproico ” https: Phylloquinone Aminocaproic Acid may increase the thrombogenic activities of Phylloquinone. A cyclic imine intermediate in the in vitro metabolic conversion of 1,6-diaminohexane to amniocaproico acid and caprolactam.
It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you.
The Annals of Pharmacotherapy. It is a derivative of the amino acid lysine.
Aminocaproic acid | C6H13NO2 – PubChem
Articles needing additional references from June All articles needing additional references Template: Andexanet alfa Aminocaproic Acid may increase the thrombogenic activities of Andexanet alfa. A Tissue-type acidl activator. A few cases of acute overdosage with intravenous administration have been reported. Rockville, MD; Jul. Prothrombin Aminocaproic Acid may increase the thrombogenic activities of Prothrombin. This article needs additional citations for verification.
Antihemophilic factor, human recombinant Aminocaproic Acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator. To view content sources and attributions, please refer to our editorial policy.
Lipoprotein 9a a has two components, apolipoprotein B, linked to apolipoprotein a. Vatreptacog alfa Aminocaproic Acid may increase the thrombogenic activities of Vatreptacog alfa.
Unsourced material may be challenged and removed. Frantisek Mares, “Process for producing caprolactam from aminocapoico acid. Texas Heart Institute Journal. Emicizumab Aminocaproic Acid may increase the thrombogenic activities of Emicizumab.